InVivoMAb anti-human/rat/fish AChR

Development of a dual-functional conjugate of antigenic peptide and Fc-III mimetics (DCAF) for targeted antibody blocking. Zhang L et al., 2019 Mar 21, Chem Sci

Antigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravis. Luo J et al., 2014 Nov 15, J Immunol

A single mutation in the acetylcholine receptor delta-subunit causes distinct effects in two types of neuromuscular synapses. Park JY et al., 2014 Jul 30, J Neurosci

Complement membrane attack is required for endplate damage and clinical disease in passive experimental myasthenia gravis in Lewis rats. Chamberlain-Banoub J et al., 2006 Nov, Clin Exp Immunol

Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Losen M et al., 2005 Oct, Brain

Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. Poea-Guyon S et al., 2005 May 15, J Immunol